Nephrology Doctors in Beckley, WV Accepting Medicare

3 Nephrology doctors found. Showing 1 - 3

Divya S. Rajan, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1832 Harper Rd, Beckley, WV 25801 Phone: 681-207-7129    Fax: 681-207-7132

Dr. Hafiz Imran Iqbal, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 242 George St, Beckley, WV 25801 Phone: 304-255-7878    Fax: 304-256-0060

Jose Jorge Gordinho, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2962 Robert C. Byrd Drive, Beckley, WV 25801 Phone: 304-254-9022    Fax: 304-254-9024

News Archive

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).

Increased activity of EHMT2 gene deficient neurons could cause autism in humans

A novel investigation into the impacts of neuronal mutations on autism-related characteristics in humans has been described in the open-access journal eLife.

ReShape Medical initiates IDE clinical study to assess effectiveness of dual-balloon device for weight loss

ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.

VeriChip to fund its existing partnership with RECEPTORS

VeriChip Corporation ("VeriChip") and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing partnership with RECEPTORS to continue the development of a triage detection system for detection of the H1N1 virus.

FDA extends CombinatoRx' Exalgo tablets NDA PDUFA review date

CombinatoRx, Incorporated today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for review of the Exalgo™ (hydromorphone HCl) extended-release tablets New Drug Application (NDA) from Monday, February 22, 2010 to Monday, March 1, 2010 due to federal government closings.

Read more Medical News

› Verified 3 days ago